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1. Introduction     
Neuropathy Target Esterase (NTE), is a membrane-bound protein found in neurons of 
vertebrates (Glynn, 1999; Atkins & Glynn, 2000; van Tienhoven et al., 2002; Li et al., 2003; 
Makhaeva et al., 2003; Kropp et al., 2004), has been shown to be necessary for embryonic 
development in mice, and is believed to be involved in cell-signaling pathways and lipid 
trafficking (Glynn, 1999).  
NTE has serine esterase activity and can hydrolyze ester, peptide, and amide bonds. The 
nucleophilic serine residue (active site) of NTE attacks the carbonyl carbon atom of the 
substrate, forming a covalent acyl-enzyme intermediate, which is subsequently hydrolyzed. 
A consequence of this reaction mechanism is that the esterase activity of NTE is susceptible 
to covalent inhibition by organophosphorus esters (OPs) with which it forms an analogous 
phosphyl-enzyme intermediate.  
Irreversible binding of some OP compounds to the active serine site results in a debilitating 
neural disease known as OP-induced delayed neuropathy (OPIDN) (Glynn, 1999).  Signs of 
OPIDN include flaccid paralysis of the lower limbs, which becomes evident two to three 
weeks after exposure to neuropathic OPs. Recovery from this disease is usually poor, and 
there is no specific treatment. In addition, mutations in the NTE gene have been linked to 
motor neuron disease (Rainier et al., 2008). 
Because NTE plays a central role in both chemically induced and spontaneously occurring 
neurological diseases, approaches that can help measure its esterase activity and inhibition 
are of tremendous scientific and commercial importance. Because NTE is difficult to 
produce for research purposes, research to study its esterase activity is typically done using 
a fragment of the NTE protein that contains the esterase activity and can be more easily 
produced. One such fragment, known as NEST, (Atkins & Glynn, 2000; Forshaw et al., 2001; 
Kropp et al., 2004) reacts with esters and inhibitors in a manner very similar to NTE.  
Conventionally, the esterase activity of NTE (or NEST) is measured using two distinct steps. 
In the first step, a solution containing phenyl valerate is brought into contact with NEST or 
NTE protein solution, whose esterase activity reacts with a portion of the artificial substrate 
phenyl valerate to form phenol.  In the second step, the concentration of phenol in the 
solution is determined either colorimetrically, in the presence of 4-amino antipyrine 
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(Kayyali et al., 1991), or electrochemically, in the presence of tyrosinase enzyme (Sigolaeva 
et al., 2001; Sokolovskaya et al., 2005).  Tyrosinase converts phenol first to catechol and then 
to o-quinone, which can be measured electrochemically at an electrode (Makhaeva et al., 
2003). The current generated by the electrode increases with the amount of o-quinone 
present, thus giving an indirect measurement of the amount of NTE esterase activity present 
during the first step. To test for esterase inhibition, this procedure is repeated both in the 
absence and presence of a putative inhibitor (e.g., an OP compound). A reduced signal 
indicates inhibition of the esterase activity. This method has the disadvantages of being 
slow, and requiring two steps, making it unsuitable for some important applications, such 
as high-throughput screening of compounds for NTE inhibition and continuous, on-line, 
environmental monitoring to detect chemical warfare agents that target NTE (Richardson et 
al., 2009).  The present chapter reviews and extends our work on the first continuous, 
electrochemical biosensor for real-time, rapid measurement of NEST (or NTE) esterase 
activity. The biosensor was fabricated by co-immobilizing NEST protein and tyrosinase 
enzyme on an electrode using the layer by layer assembly approach by Decher (Decher, 
1997). To our knowledge, this is the first time NEST has been immobilized in an active 
conformation on an electrode. Potential applications of this sensor include detecting the 
presence of chemical weapons that target NTE, screening industrial and agricultural OP 
compounds for NTE inhibition, studying the fundamental reaction kinetics of NTE, and 
investigating the effect of NTE mutations found in motor neuron disease patients on NTE’s 
enzymatic properties. The same approach can be used for activitiy measurements of other 
serine hydrolases, such as acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) 
(Kohli et al., 2007).  
2. Experimental section 
Materials 
Thioctic acid, poly-L-lysine (PLL) (molecular weight ~ 15,000), tyrosinase (Tyr), sodium 
phosphate (monobasic and dibasic), ethylenediaminetetraacetic acid (EDTA), sodium 
chloride, 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate (CHAPS) and 
isopropyl thiogalactoside (IPTG) were obtained from Sigma (St. Louis, MO). Ultrapure 
water (18.2MΩ) was supplied by a Nanopure-UV four-stage purifier (Barnstead 
International, Dubuque, IA); the purifier was equipped with a UV source and a final 0.2 µm 
filter. 
NEST expression and purification 
NEST was expressed and purified according to published procedures (Atkins & Glynn, 
2000). Briefly, a DNA fragment encoding NEST was cloned into pET-21b vector, and the 
resulting expression vector was transformed into E. coli BL21 (DE3). An overnight culture of 
transformed E. coli was inoculated with M9 media containing ampicillin and grown in a 
fermentor. IPTG was added to the resulting cell culture after a day to induce the expression 
of NEST. The resulting cells were collected 4 h after induction by centrifugation and 
subjected to protein expression techniques. Briefly, 5 g of cell paste was suspended in 30 ml 
of PEN buffer (50mM sodium phosphate/0.3 M NaCl/0.5 mM EDTA, pH 7.8) containing 2% 
(w/v) CHAPS and tip sonicated four times. The cell lysate was centrifuged at 2000g for 30 
min at 4°C, the supernatant was collected, and about 7 mL of supernatant was added to a 
mini column (volume 10 mL) containing 3 mL of Ni-nitrilotriacetic acid (NTA) resin. The 
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mini column was rotated at room temperature for 20 min, centrifuged at 2000g for 20 sec 
and then the top solution was drawn off. The histidine-tagged NEST was eluted from the 
Ni-NTA resin using 10 mL of PEN buffer containing 0.3% (w/v) CHAPS and 0.3 M 
imidazole. The protein purity was determined using SDS-PAGE and protein concentration 
was determined using BioRad Dc protein assay kit. For long term storage, 25% (v/v) 
glycerol was added to the protein solution, which was then stored at -20°C.  
Preparation of gold electrode for NEST biosensor  
Tyrosinase is a copper-containing oxidase (Forzani et al., 2000; Coche-Guerente et al., 2001), 
which possesses two different activities, as illustrated in reaction 1.  
 phenol → catechol → o-quinone + H2O  (1)                          
The first step is referred to as the enzyme’s hydroxylase activity (also known as cresolase 
activity) where phenol is hydroxylated by the aid of molecular oxygen to produce catechol. 
In the second step, known as the catecholase activity, the enzyme oxidizes catechol to o-
quinone and is simultaneously oxidized by oxygen to its original form, with the production 
of water. The reaction product, o-quinone, is electrochemically active and can be reduced 
back to the catechol form at low applied potentials, as illustrated in reaction 2.   
 o-quinone + 2H+ + 2e- → catechol  (2) 
We exploited these characteristics of tyrosinase to fabricate a NEST biosensor, capable of 
measuring the NEST’s esterase activity and its inhibition, by co-immobilizing NEST and 
tyrosinase on a gold electrode using the layer by layer assembly approach.  
The molecular architecture of the biosensor interfaces are shown schematically in Figure 1 
(a) & (b). Two molecular self-assembly approaches, (a) layer-by-layer (LBL) assembly 
(Decher, 1997) and (b) tethered lipid bilayer membranes (tBLM) (Kohli et al., 2006), were 
utilized in constructing nanostructured NEST biosensors. Gold electrodes cleaned in 
piranha solution were dipped in a 5 mM solution of thioctic acid in ethanol for 30 min. The 
electrodes were washed with ethanol, dried under nitrogen and dipped in PLL solution for 
45 min. The PLL solution was prepared by adding 12 mg of PLL in 50 mL of 20 mM 
phosphate buffer (pH 8.5). The electrodes were then rinsed with water and dipped in an 
aqueous solution of tyrosinase (Tyr) (0.2 mg/ml) for 1 h. The last two steps were repeated 
varying number times to create PLL-Tyr bilayers with PLL being the topmost layer. The 
electrodes were washed with water and dipped in a solution of NEST protein (0.1 mg/ml) 
in 100 mM phosphate buffer, pH (7.0) for 1 h.  The electrodes were then washed with water, 
dried under nitrogen and dipped in phosphate buffer (0.1 M, pH 7.0) for testing. 
Preparation of phenyl valerate solution 
To prepare phenyl valerate solution, 15 mg of phenyl valerate was dissolved in 1 mL of 
dimethylformamide (DMF), and 15 mL of water containing 0.03% (w/v) Triton-X100 was 
added slowly under vigorous stirring. For potential step voltammetry experiments, small 
aliquots of the resulting phenyl valerate micellar solution (5.286 mM nominal concentration) 
were added to the phosphate buffer to obtain the desired apparent concentrations. 
Ellipsometry 
Ellipsometric measurements were obtained with a rotating analyzer ellipsometer (model M-
44; J.A. Woollan Co. Inc., Lincoln, NE) using WVASE32 software. The thickness values for 
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Fig. 1. Molecular architecture of the nanostructured NEST biosensors via (a) layer-by-layer 
(LBL) deposition scheme as adapted/reproduced with permission from (Kohli et al., 2007; 
Srivastava, 2008), and (b) tethered lipid bilayer membranes (tBLM) adapted with permission 
from (Kohli et al., 2006). 
dried films were determined using 44 wavelengths between 414.0 and 736.1 nm. The angle 
of incidence was 75° for all experiments. Refractive indices of films containing PLL and 
proteins was assumed to be n=1.5, k=0. These optical constants compare well with those 
determined for 4 bilayer films consisting of poly-L-lysine and tyrosinase using ellipsometry. 
Potential step voltammetry and other measurements 
The electrodes (sensors) were maintained at a potential of -100 mV (vs Ag/AgCl reference 
electrode) using a BAS CV-50W electrochemical analyzer. The esterase activity of the NEST 
biosensor was monitored by measuring the output current for a variety of phenyl valerate 
concentrations, under stirred conditions. The NEST protein converts phenyl valerate to 
phenol, which gets converted to o-quinone by tyrosinase. The o-quinone gets reduced at the 
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electrode’s surface, resulting in the generation of current. The electroreduction of o-quinone 
produces catechol, which again gets converted to o-quinone by tyrosinase, thus amplifying 
the signal.  
To measure inhibition of the esterase activity, a known quantity of phenyl valerate was 
added to the phosphate buffer (pH 7.0), under stirred conditions. After the stabilization of 
current, a known amount of NEST inhibitor was added, and the resulting drop in current 
was measured.  
3. Results and discussion 
We have tested both LBL assembly and tBLM methods to fabricate novel nanostructured 
NEST biosensors, as schemed in Figure 1 (a) & (b) (Kohli et al., 2006; Kohli et al., 2007; 
Srivastava, 2008).  In this Chapter, we will focus on the former approach.  The latter is 
briefly summarized as below.  The phenyl valerate assay was used to confirm whether 
tBLMs could immobilize NEST in a functional conformation. Incubation of phenyl valerate 
with NEST-containing BLMs on gold resulted in the production of about 2 ± 0.19 nmol/min 
of phenol over an area of 1 cm2. Incubation of phenyl valerate with NEST-DOPC liposomes 
in solution resulted in the production of 40 ± 1.2 nmol/min of phenol per μg of NEST 
protein. This result suggests the immobilization of approximately 50 ng/cm2 of active NEST 
in tBLMs. To our knowledge, this is the first time NEST has been immobilized in an active 
conformation on a surface (Kohli et al., 2006). 
3.1 Ellipsometry  
Ellipsometry were used to confirm the deposition of different layers that make up the NEST 
biosensor. As shown in Figure 2, the thickness increase following the addition of the first 
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Fig. 2. Ellipsometric thicknesses after the successive addition of following layers: thioctic 
acid (point a), PLL-Tyr first bilayer (point b), PLL-Tyr second bilayer (point c), PLL-Tyr 
third bilayer (point d), and PLL and NEST final bilayer (point e). Reproduced with 
permission from (Kohli et al., 2007). 
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PLL and Tyr bilayer was approximately 9.3 ± 0.4 nm. The thickness increase for the next two 
PLL-Tyr bilayers was approximately the same and equal to 7.2± 0.3 nm. The thickness 
increase following the addition of final PLL-NEST bilayer was approximately 6.6 ± 0.3 nm. 
3.2 Dependence of current response on working potential and pH 
The various experimental parameters (such as pH and applied potential), which can affect 
the amperometric determination of phenyl valerate, were optimized. The effect of applied 
potential on the amperometric response of the sensor was tested in the range between 0.05 
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Fig. 3. (a) Effect of working potential on the response current of the enzyme electrode in 0.1 
M phosphate buffer (pH 7.0) with (i) and without (ii) 12 µM phenyl valerate solution, in 0.1 
M phosphate buffer at an applied potential of -0.1 V (vs Ag/AgCl). (b) Effect of pH on the 
response current of the electrode, in the presence of 12 µM phenyl valerate solution, in 0.1 M 
phosphate buffer at an applied potential of -0.1V (vs Ag/AgCl). Rreproduced with 
permission from (Kohli et al., 2007). 
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and -0.20 V. Figure 3a illustrates the signal and background for the whole range. The highest 
signal-to background ratio, was obtained at -0.1 V. At a working potential more negative 
than -0.1 V, higher signals were obtained, but the background current also increased 
distinctly. Therefore, a working potential of -0.1 V was used for further studies.  The effect of 
pH was also studied in the pH range 5.5 to 8.0 in 0.1 M phosphate buffer at working 
potential of -0.1 V. As shown in Figure 3b, the response current attained a maximum value 
at pH 7.0. This pH was used for further studies. 
3.3 Measurement of esterase activity using NEST biosensor  
Figure 4a displays a typical current-time response under the optimal experimental 
conditions after the successive addition of aliquots of 4 µM phenyl valerate to the phosphate  
 
 
 
(a) 
 
(b) 
Fig. 4. (a) Current time response of the NEST biosensor to the addition of aliquots of 4 µM 
phenyl valerate, in 0.1 M phosphate buffer, pH 7.0, at an applied potential of -0.1V (vs 
Ag/AgCl). (b) Calibration plot.  Reproduced with permission from (Kohli et al., 2007). 
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buffer. A well defined reduction current, proportional to the amount of phenyl valerate, was 
observed. The response time of the electrode was less then 20 seconds, due to the nano-scale 
thickness of the interface. The response to phenyl valerate was linear (r=0.991) in the range 
0.5 µM to 12 µM, and it reached saturation at approx. 30 µM (Figure 4b). The limit of 
detection was 0.5 µM at a signal-to-noise ratio of 3. The reproducibility of the sensor was 
investigated at a phenyl valerate concentration of 4 µM; the mean current was 
approximately 348 nAcm-2, with a relative standard deviation of 9.9%. Figure 5 shows a 
control experiment which was done on an electrode containing only poly-L-lysine and 
tyrosinase bilayers. As expected, a relatively very small rise in steady state current was 
observed on the addition of phenyl valerate. The small rise can be attributed to the presence 
of a small amount of phenol produced due to auto-hydrolysis of phenyl valerate solution. 
 
 
Fig. 5. Control experiment: Current time response on an electrode containing only 
tyrosinase. The electrode was assembled in exactly the same way as NEST biosensor, except 
that the final NEST layer was not deposited. The  Reproduced with permission from (Kohli 
et al., 2007). 
3.4 Inhibition of esterase activity 
To measure inhibition of the esterase activity, an aliquot of phenyl valerate was added to the 
phosphate buffer. After a steady biosensor signal was obtained, a known quantity of 
phenylmethylsulfonyl fluoride (PMSF), a non-neuropathic compound previously shown to 
inhibit NEST (or NTE) esterase activity, was added to the phosphate buffer solution, and the 
resulting drop in current was measured. At very low concentration there was not  an 
appreciable drop in signal as shown in Figure 6. As shown in Figure 7, however, a 20% (± 
3%) decrease in response on the addition of 100 µM PMSF and a 70% (± 4%) decrease on the 
addition of 1000 µM PMSF was observed as shown in Figure 8. PMSF inhibition of NEST 
esterase activity reduces the amount of phenol and subsequently o-quinone produced. 
Therefore, less o-quinone gets reduced at the electrode surface, leading to a drop in current. 
These results suggest that the NEST biosensor can be used for concentration-dependent 
detection of NEST inhibitors.  
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Fig. 6. Current time response of NEST biosensor to the addition of phenyl valerate in 
phosphate buffer (0.1 M, pH 7.0) to obtain a final phenyl valerate concentration of 8 μM 
followed by the addition of NEST inhibitor PMSF to obtain a final PMSF concentration of 10 
μM.  Reproduced with permission from (Kohli et al., 2007). 
 
Fig. 7. Current time response of NEST biosensor to the addition of phenyl valerate in 
phosphate buffer (0.1 M, pH 7.0) to obtain a final phenyl valerate concentration of 8 μM 
followed by the addition of NEST inhibitor PMSF to obtain a final PMSF concentration of 
100 μM. Reproduced with permission from (Kohli et al., 2007). 
3.5 Higher-sensitivity NEST biosensor 
NEST biosensor sensitivity could be increased by increasing the number of bilayers of PLL-
Tyr to six. As discussed by Kohli et. al (Kohli et al., 2007) in the mathematical model 
developed for the NEST biosensor, the sensitivity can be improved more efficiently by 
increasing the amount of tyrosinase immobilized on the surface rather than increasing the 
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Fig. 8. Current versus time response of the NEST biosensor to the addition of phenyl 
valerate in phosphate buffer (0.1 M , pH 7.0) to obtain a final phenyl valerate concentration 
of 8 μM followed by the addition of the NEST inhibitor PMSF to obtain a final PMSF 
concentration of 1000 μM.  Reproduced with permission from (Kohli et al., 2007). 
amount of NEST. Hence, we developed a higher-sensitivity sensor by increasing the bilayers to 
six as the sensitivity of the catechol sensor was maximized with 6 bilayers (Srivastava, 2008). 
The same procedure used previously for the NEST biosensor was followed to fabricate the 
higher-sensitivity biosensor. The gold electrode was first modified with thioctic acid 
followed by the deposition of PLL-Tyr bilayers. After addition of 6 bilayers a layer of NEST 
was added. The sensor was tested for NEST activity by phenyl valerate assay. The 
sensitivity went up to 847 ± 158 nA cm-2µM-1 for the addition of phenyl valerate. The plot 
for phenyl valerate is shown in Figure 9. NEST inhibition was also done by addition of 100 
µM and 1mM of PMSF. The decrease in current was the same as observed with 3 bilayers of 
NEST. The plots for inhibition of NEST on 6 bilayers of PLL-Tyr are shown in Figures 10 and 
11 for PMSF concentrations of 100 µM and 1 mM, respectively. There was no remarkable 
decrease in current with 10 µM addition of PMSF (data not shown). Hence, a higher- 
sensitivity NEST biosensor can be obtained by increasing the amount of tyrosinase on the 
interface. It also implies that better sensors can be prepared with marginal increment to cost 
as tyrosinase is commercially available and can be easily deposited onto the electrode by 
using LBL deposition.  
3.6 Significance of NEST biosensor 
This new biosensor approach to measuring NEST esterase activity and its inhibition can in 
principle easily be extended to full length NTE. The approach offers several advantages over 
the old two step method.  First, it requires only a single step to measure NEST (or NTE) 
esterase activity. Because the NEST esterase activity is co-immobilized with tyrosinase on 
the sensor interface, the presence of phenyl valerate triggers sequential reactions that result 
in an electrical signal. Second, the nanometer-scale thickness of layers in the sensing 
interface provides a very short diffusion path giving a rapid response time (less than 10 
seconds).  Third, the biosensor is suitable for continuous, real-time measurements of esterase 
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Fig. 9. Current versus time response of the higher-sensitivity NEST biosensor with 6 bilayers 
of PLL-Tyr underneath the NEST layer. The sensor was tested in phosphate buffer (0.1M) 
with electrode maintained -0.1V vs Ag/AgCl reference electrode. For the control the 
electrode was prepared in exactly the same manner but the NEST layer was not added.  
Reproduced with permission from (Srivastava, 2008). 
 
 
 
Fig. 10. Current response of the higher-sensitivity NEST biosensor with 6 layers of PLL-Tyr 
followed by inhibition of NEST by addition of 0.1 mM PMSF. First phenyl valerate was 
added to get the final substrate concentration of 8 µM in bulk solution. The current response 
was allowed to achieve steady state before addition of an aliquot of PMSF to get a final 
inhibitor concentration of 0.1 mM.  Reproduced with permission from (Srivastava, 2008). 
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Fig. 11. Current response of the higher-sensitivity NEST biosensor with 6 layers of PLL-Tyr 
and followed by inhibition of NEST by addition of 1 mM PMSF.  First phenyl valerate was 
added to get the final substrate concentration of 8 µM in bulk solution. The current response 
was allowed to achieve steady state before addition of an aliquot of PMSF to get a final 
inhibitor concentration of 1 mM.  Reproduced with permission from (Srivastava, 2008). 
activity. Fourth, the biosensor is designed to achieve signal amplification via recycling of o-
quinone to catechol, thus increasing the sensitivity of the sensor. Fifth, the biosensor 
interface is generated by flexible, layer-by-layer (LBL), molecular self-assembly methods 
that would allow it to be assembled on electrodes inside microfluidic channels, thus 
enabling the production of high-density biosensor arrays consisting of various esterases 
(e.g., AchE and BchE) for high-throughput applications. 
This combination of desirable properties makes this interface well suited for important 
applications, including studying the kinetic properties of esterases such as NEST protein, 
high-throughput screening of compounds for NEST (or NTE) inhibition and continuous, on-
line, environmental monitoring to detect chemical warfare agents that target NEST (or NTE) 
and other esterases.  
4. Conclusions 
A biosensor has been developed that allows the activity of NEST to be measured 
continuously. The biosensor was fabricated by a layer-by-layer assembly approach to co-
immobilize NEST and tyrosinase on a gold electrode.  Ellipsometry provided evidence for 
the sequential assembly of the multiple layers that make up the interface. Constant potential 
voltammetry allowed NEST enzyme activity to be measured with a rapid response time (< 
10 s). The biosensor gave a concentration-dependent response to a known non-neuropathic 
(PMSF) NEST inhibitor. 
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